Latest & greatest articles for type 2 diabetes

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on type 2 diabetes or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on type 2 diabetes and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for type 2 diabetes

121. A juxtaposition of safety outcomes between various doses of sodium-glucose co-transporter inhibitors, in insulin-treated type-1 diabetes mellitus patients: a protocol for systematic review and meta-analysis of randomized controlled trials Full Text available with Trip Pro

A juxtaposition of safety outcomes between various doses of sodium-glucose co-transporter inhibitors, in insulin-treated type-1 diabetes mellitus patients: a protocol for systematic review and meta-analysis of randomized controlled trials A juxtaposition of safety outcomes between various doses of sodium-glucose co-transporter inhibitors, in insulin-treated type-1 diabetes mellitus patients: a protocol for systematic review and meta-analysis of randomized controlled trials | Journal of Ideas (...) in Health Quick jump to page content Toggle navigation Keyword : Search Articles DOI Article Sidebar Published Aug 20, 2020 Main Article Content Abstract Background: Several clinical trials have tested the safety profile of sodium-glucose co-transport inhibitors’ (SGLTis) in adult type 1 diabetes mellitus (T1DM) patients. However, no systematic review has yet compared its variation between large and low dose SGLTis. Henceforth, a review protocol is proposed here to review it. Methods: Different

2020 Journal of Ideas in Health

123. Comparative Effectiveness of Glucose-Lowering Drugs for Type 2 Diabetes: A Systematic Review and Network Meta-analysis. (Abstract)

Comparative Effectiveness of Glucose-Lowering Drugs for Type 2 Diabetes: A Systematic Review and Network Meta-analysis. Several pharmacologic options for type 2 diabetes are available.To compare benefits and harms of glucose-lowering drugs in adults with type 2 diabetes.Several databases from inception through 18 December 2019 and ClinicalTrials.gov on 10 April 2020.English-language randomized trials that had at least 24 weeks of intervention and assessed the effects of glucose-lowering drugs (...) exenatide, and dapagliflozin reduced all-cause mortality. Oral semaglutide, empagliflozin, and liraglutide also reduced cardiovascular death. Odds of stroke were lower with subcutaneous semaglutide and dulaglutide. Sodium-glucose cotransporter-2 (SGLT-2) inhibitors reduced heart failure hospitalization and end-stage renal disease. Subcutaneous semaglutide and canagliflozin increased diabetic retinopathy and amputation, respectively.Inconsistent definitions of cardiovascular risk and low-level confidence

2020 Annals of Internal Medicine

124. Comparative Effectiveness of Dulaglutide Versus Iiraglutide in Asian type 2 Diabetes Patients: A Multi-Institutional Cohort Study and Meta-Analysis Full Text available with Trip Pro

Comparative Effectiveness of Dulaglutide Versus Iiraglutide in Asian type 2 Diabetes Patients: A Multi-Institutional Cohort Study and Meta-Analysis Comparative Effectiveness of Dulaglutide Versus Iiraglutide in Asian type 2 Diabetes Patients: A Multi-Institutional Cohort Study and Meta-Analysis | Research Square Browse Tools & Services Your Cart See the published version of this article at . This is a preprint, a preliminary version of a manuscript that has not completed peer review (...) at a journal. Research Square does not conduct peer review prior to posting preprints. The posting of a preprint on this server should not be interpreted as an endorsement of its validity or suitability for dissemination as established information or for guiding clinical practice. Original investigation Comparative Effectiveness of Dulaglutide Versus Iiraglutide in Asian type 2 Diabetes Patients: A Multi-Institutional Cohort Study and Meta-Analysis Kai-Cheng Chang, Shih-Chieh Shao, Shihchen Kuo, Chen-Yi

2020 Research Square

125. Efficacy and safety of glucokinase activators for type 2 diabetes mellitus therapy: A meta-analysis of double-blind randomized controlled trials Full Text available with Trip Pro

Efficacy and safety of glucokinase activators for type 2 diabetes mellitus therapy: A meta-analysis of double-blind randomized controlled trials Efficacy and safety of glucokinase activators for type 2 diabetes mellitus therapy: A meta-analysis of double-blind randomized controlled trials - Authorea "); } "); } "); } "); } "); } "); } "); } AUTHOREA loading page this is for holding javascript data Efficacy and safety of glucokinase activators for type 2 diabetes mellitus therapy: A meta (...) -analysis of double-blind randomized controlled trials +2 Yiqian Qu , Keer Wang , Shuyuan Lin , Lingyong Cao , Zhenghao Xu Yiqian Qu Zhejiang Chinese Medical University Keer Wang Zhejiang Chinese Medical University Shuyuan Lin Zhejiang Chinese Medical University Lingyong Cao Zhejiang Chinese Medical University Zhenghao Xu Zhejiang Chinese Medical University Abstract Abstract Objectives: To assess the efficacy and safety of oral glucokinase activator (GKA) in the treatment of type 2 diabetes mellitus

2020 Authorea, Inc.

126. Randomized Double-Blind Clinical Trial Comparing Ultra Rapid Lispro With Lispro in a Basal-Bolus Regimen in Patients With Type 2 Diabetes: PRONTO-T2D Full Text available with Trip Pro

Randomized Double-Blind Clinical Trial Comparing Ultra Rapid Lispro With Lispro in a Basal-Bolus Regimen in Patients With Type 2 Diabetes: PRONTO-T2D Randomized Double-Blind Clinical Trial Comparing Ultra Rapid Lispro With Lispro in a Basal-Bolus Regimen in Patients With Type 2 Diabetes: PRONTO-T2D - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features (...) Rapid Lispro With Lispro in a Basal-Bolus Regimen in Patients With Type 2 Diabetes: PRONTO-T2D , , , , , Affiliations Expand Affiliations 1 Texas Diabetes & Endocrinology, Austin, TX. 2 Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN. 3 National Research Institute, Los Angeles, CA. 4 Jinnouchi Hospital, Kumamoto, Japan. PMID: 32616612 DOI: Item in Clipboard Randomized Double-Blind Clinical Trial Comparing Ultra Rapid Lispro With Lispro in a Basal-Bolus Regimen in Patients With Type 2

2020 EvidenceUpdates

127. Effect of dulaglutide on cognitive impairment in type 2 diabetes: an exploratory analysis of the REWIND trial

Effect of dulaglutide on cognitive impairment in type 2 diabetes: an exploratory analysis of the REWIND trial Effect of dulaglutide on cognitive impairment in type 2 diabetes: an exploratory analysis of the REWIND trial - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. COVID-19 is an emerging, rapidly evolving situation. Get (...) there aren't any new results Optional text in email: Save Cancel Create a file for external citation management software Create file Cancel Your RSS Feed Name of RSS Feed: Number of items displayed: Create RSS Cancel RSS Link Copy Actions Cite Share Permalink Copy Page navigation Lancet Neurol Actions . 2020 Jul;19(7):582-590. doi: 10.1016/S1474-4422(20)30173-3. Effect of dulaglutide on cognitive impairment in type 2 diabetes: an exploratory analysis of the REWIND trial

2020 EvidenceUpdates

128. Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes

Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes EXPERT CONSENSUS DECISION PATHWAY 2020 Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes A Report of the American College of Cardiology Solution Set Oversight Committee Endorsed by the American Diabetes Association Writing Committee Sandeep R. Das, MD, MPH, FACC, Co-Chair Brendan M. Everett, MD, MPH, FACC, Co-Chair Kim K. Birtcher, PHARMD, MS (...) .2020Expertconsensusdecisionpathwayonnoveltherapiesforcardiovascularrisk reduction in patients with type 2 diabetes: a report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol 2020;XX:XXX–XX. Copies: This document is available on the World Wide Web site of the American College of Cardiology (www.acc.org). For copies of this document, please contact Elsevier Inc. Reprint Department via fax (212) 633-3820 or e-mail (reprints@elsevier.com). Permissions: Multiple copies, modi?cation, alteration, enhancement, and/or distribution

2020 American College of Cardiology

129. Mobile-Enhanced Peer Support for African Americans with Type 2 Diabetes: a Randomized Controlled Trial

Mobile-Enhanced Peer Support for African Americans with Type 2 Diabetes: a Randomized Controlled Trial Mobile-Enhanced Peer Support for African Americans with Type 2 Diabetes: a Randomized Controlled Trial - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. COVID-19 is an emerging, rapidly evolving situation. Get the latest public (...) new results Optional text in email: Save Cancel Create a file for external citation management software Create file Cancel Your RSS Feed Name of RSS Feed: Number of items displayed: Create RSS Cancel RSS Link Copy Actions Cite Share Permalink Copy Page navigation J Gen Intern Med Actions . 2020 Jul 22. doi: 10.1007/s11606-020-06011-w. Online ahead of print. Mobile-Enhanced Peer Support for African Americans with Type 2 Diabetes: a Randomized Controlled Trial , , , , Affiliations Expand

2020 EvidenceUpdates

130. Costs and Its Drivers for Diabetes Mellitus Type 2 Patients in France and Germany: A Systematic Review of Economic Studies Full Text available with Trip Pro

Costs and Its Drivers for Diabetes Mellitus Type 2 Patients in France and Germany: A Systematic Review of Economic Studies Costs and Its Drivers for Diabetes Mellitus Type 2 Patients in France and Germany: A Systematic Review of Economic Studies | Research Square Browse Tools & Services Your Cart See the published version of this article at . This is a preprint, a preliminary version of a manuscript that has not completed peer review at a journal. Research Square does not conduct peer review (...) prior to posting preprints. The posting of a preprint on this server should not be interpreted as an endorsement of its validity or suitability for dissemination as established information or for guiding clinical practice. Research article Costs and Its Drivers for Diabetes Mellitus Type 2 Patients in France and Germany: A Systematic Review of Economic Studies Constance Stegbauer, Camilla Falivena, Ariadna Moreno, Anna Hentschel, Magda Rosenmöller, Tim Heise, Joachim Szecsenyi, Freimut Schliess

2020 Research Square

131. Safety and efficacy of hypoglycemic agents in patients with type 2 diabetes mellitus (T2DM): protocol for an overview of systematic reviews based on network meta-analysis Full Text available with Trip Pro

Safety and efficacy of hypoglycemic agents in patients with type 2 diabetes mellitus (T2DM): protocol for an overview of systematic reviews based on network meta-analysis Inplasy Protocol 582 - INPLASY.COM International Platform of Registered Systematic Review and Meta-analysis Protocols Main Menu Share this: Copyright © 2021 INPLASY.COM Powered by INPLASY.COM

2020 INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols

132. The prevalence of urinary tract infections in type 2 diabetic patients: a systematic review and meta-analysis Full Text available with Trip Pro

The prevalence of urinary tract infections in type 2 diabetic patients: a systematic review and meta-analysis The prevalence of urinary tract infections in type 2 diabetic patients: a systematic review and meta-analysis | Research Square Browse Tools & Services Your Cart This is a preprint, a preliminary version of a manuscript that has not completed peer review at a journal. Research Square does not conduct peer review prior to posting preprints. The posting of a preprint on this server should (...) not be interpreted as an endorsement of its validity or suitability for dissemination as established information or for guiding clinical practice. Research The prevalence of urinary tract infections in type 2 diabetic patients: a systematic review and meta-analysis Aliakbar Vaisi-Raygani, Nader Salari, Mohammad mahdi Karami, Shadi Bokaee, Masoud Mohammadi, Rostam Jalali, Maryam Chaleshgar, Alireza Daneshkhah, Shamarina Shohaimi Aliakbar Vaisi-Raygani Kermanshah University of Medical Sciences Nader Salari

2020 Research Square

138. Association of plasma biomarkers of fruit and vegetable intake with incident type 2 diabetes: EPIC-InterAct case-cohort study in eight European countries. Full Text available with Trip Pro

Association of plasma biomarkers of fruit and vegetable intake with incident type 2 diabetes: EPIC-InterAct case-cohort study in eight European countries. To investigate the association of plasma vitamin C and carotenoids, as indicators of fruit and vegetable intake, with the risk of type 2 diabetes.Prospective case-cohort study.Populations from eight European countries.9754 participants with incident type 2 diabetes, and a subcohort of 13 662 individuals from the European Prospective (...) Investigation into Cancer and Nutrition (EPIC) cohort of 340 234 participants: EPIC-InterAct case-cohort study.Incident type 2 diabetes.In a multivariable adjusted model, higher plasma vitamin C was associated with a lower risk of developing type 2 diabetes (hazard ratio per standard deviation 0.82, 95% confidence interval 0.76 to 0.89). A similar inverse association was shown for total carotenoids (hazard ratio per standard deviation 0.75, 0.68 to 0.82). A composite biomarker score (split into five equal

2020 BMJ

139. Intake of whole grain foods and risk of type 2 diabetes: results from three prospective cohort studies. Full Text available with Trip Pro

Intake of whole grain foods and risk of type 2 diabetes: results from three prospective cohort studies. To examine the associations between the intake of total and individual whole grain foods and the risk of type 2 diabetes.Prospective cohort studies.Nurses' Health Study (1984-2014), Nurses' Health Study II (1991-2017), and Health Professionals Follow-Up Study (1986-2016), United States.158 259 women and 36 525 men who did not have type 2 diabetes, cardiovascular disease, or cancer (...) at baseline.Self-reports of incident type 2 diabetes by participants identified through follow-up questionnaires and confirmed by a validated supplementary questionnaire.During 4 618 796 person years of follow-up, 18 629 participants with type 2 diabetes were identified. Total whole grain consumption was categorized into five equal groups of servings a day for the three cohorts. After adjusting for lifestyle and dietary risk factors for diabetes, participants in the highest category for total whole grain

2020 BMJ

140. Hypoglycemic agents for non-alcoholic fatty liver disease with type 2 diabetes mellitus: A protocol for systematic review and network meta-analysis Full Text available with Trip Pro

Hypoglycemic agents for non-alcoholic fatty liver disease with type 2 diabetes mellitus: A protocol for systematic review and network meta-analysis Inplasy Protocol 480 - INPLASY.COM International Platform of Registered Systematic Review and Meta-analysis Protocols Main Menu Share this: Copyright © 2021 INPLASY.COM Powered by INPLASY.COM

2020 INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols